Savior Lifetec Corporation

Taipei Exchange 4167.TWO

Savior Lifetec Corporation Goodwill for the year ending December 31, 2023: USD 0.00

Savior Lifetec Corporation Goodwill is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Savior Lifetec Corporation Goodwill for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
Savior Lifetec Corporation Goodwill for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
Savior Lifetec Corporation Goodwill for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
Savior Lifetec Corporation Goodwill for the year ending December 31, 2019 was USD 0.00, a 0.00% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Taipei Exchange: 4167.TWO

Savior Lifetec Corporation

CEO	Mr. Chih-Fang Chen
IPO Date	Dec. 21, 2012
Location	Taiwan
Headquarters	29, Ke-Jhong Road
Employees	384
Sector	Consumers Staples
Industries Cleaning Supplies Biotechnology Drugstores & Retail Pharmacies Fertilizers Personal Care Petrochemicals Pharmaceuticals Plastics

Description

Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

Key trends

Past 5 years